SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan

Amy Body, Catherine Martin, Lucy Busija, Luxi Lal, Elizabeth Ahern, Raina C MacIntyre, Eva Segelov
doi: https://doi.org/10.1101/2023.02.26.23286261

Article Information

doi 
https://doi.org/10.1101/2023.02.26.23286261
History 
  • March 1, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Amy Body1,2,
  2. Catherine Martin1,
  3. Lucy Busija1,
  4. Luxi Lal1,2,
  5. Elizabeth Ahern1,2,*,
  6. Raina C MacIntyre3 and
  7. Eva Segelov1,2,4
  1. 1Monash University, Victoria, Australia
  2. 2Monash Health, Clayton, Victoria, Australia
  3. 3The Kirby Institute @ The University of New South Wales, Australia
  4. 4University of Bern, Switzerland
  1. ↵* Corresponding author; email: elizabeth.ahern{at}monash.edu
Back to top
Posted March 01, 2023.
Download PDF
Data/Code
Email
SARS-CoV-2 post-vaccine surveillance studies in Australian children and adults with cancer: SerOzNET Statistical Analysis Plan
Amy Body, Catherine Martin, Lucy Busija, Luxi Lal, Elizabeth Ahern, Raina C MacIntyre, Eva Segelov
medRxiv 2023.02.26.23286261; doi: https://doi.org/10.1101/2023.02.26.23286261
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area